Richard Harris
-
Drugs that can help keep COVID-19 patients out of the hospital are playing only a small role in Michigan, where the pandemic is accelerating. Logistical challenges are to blame.
-
Government health officials are recommending a "pause" in vaccinations with the Johnson & Johnson COVID-19 vaccine. We're answering your questions as we learn more.
-
Researchers are reporting some progress in their search for drugs that tamp down the overwhelming immune reaction that can kill a patient with COVID-19.
-
Many doctors have used antibiotics to treat COVID-19 patients, but that's largely unnecessary — and could even promote drug-resistant germs.
-
Infusing blood plasma from people who have recovered from COVID-19 into sick patients looks good on paper. But studies of the treatment haven't found benefits.
-
People who have been sick with COVID-19 may need only one dose of the normally two-shot vaccines. If that became policy it could extend vaccine supplies, but logistical challenges are daunting.
-
Researchers are trying to learn more about COVID-19 vaccines from original study participants. The quest is hampered because many people who first received a placebo shot are opting for the vaccine.
-
Scientists say the pandemic will end in the U.S. only when we achieve what's called herd immunity. Play with our simulations to see how immunity can stop an outbreak in its tracks.
-
COVID-19 vaccines appear to work against the new coronavirus strains, though scientists are warily watching a variant first seen in South Africa. Vaccines may need updates to keep pace with the virus.
-
At least 70% of people will need to be immune from the coronavirus before COVID-19 can recede through a process known as herd immunity. Vaccines can play a role. But reaching the goal won't be easy.
